PCR analysis of the genomes of 18 different African swine fever virus (ASFV) isolates showed that the l14L open reading frame (ORF) was present as either a long form or short form in all of the isolates. Sequencing of the ORF from eight isolates confirmed that both forms of the ORF were well conserved. Antisera raised against the l14L protein identified the long form of the protein as a 21 kDa protein expressed late during ASFV infection. Immunofluorescent analysis of transiently expressed haemagglutinin-tagged forms of the l14L protein showed that the long form of the protein localized predominantly to the nucleus and within the nucleoli. In contrast, although the short form of the protein was also present predominantly in the nucleus, it did not localize to the nucleoli. Deletion of the N-terminal 14 amino acids from the long form of the l14L protein, which includes a high proportion of basic Arg/Lys residues, abolished the specific nucleolar localization of the protein, although the protein was still present in the nucleus. Addition of this 14 amino acid sequence to β-galactosidase or replacement of the N-terminal 14 amino acids of the l14L short form with those from the long form directed both of these modified proteins to the nucleolus. This indicates that this 14 amino acid sequence contains all the signals required for nucleolar localization.
Introduction
African swine fever virus (ASFV) is a large, icosahedral virus that replicates in the cytoplasm of infected cells, contains a large DNA genome (170-190 kbp) and has a tropism for macrophages. ASFV has similarities in its replication strategy to that of the poxviruses (reviewed by Vinuela, 1985 ; Costa, 1990) but its structure is different and it has been placed in a separate genus (African swine fever-like viruses), of which it is the only member .
Sequencing of the ASFV genome has identified a number of genes that may be important for virus virulence (Dixon et al., a similar N-terminal basic domain, but these domains are not present in the MyD116 or GADD34 proteins.
The function of the HSV ICP34.5 protein is cell type and cell state specific . In mouse 3T6 cells, HSV ICP34.5 deletion mutants are defective in maturation and egress of virus from infected cells . In human neuroblastoma cell lines, ICP34.5 deletion mutants cause shut-off of host protein synthesis. This occurs after phosphorylation of the translation initiation factor eIF-2α and is mediated by PKR kinase (Chou et al., 1995) . The conserved C-terminal domain of the protein is needed for this function, although it may not be sufficient, and the similar domain from the MyD116 protein can substitute for that of ICP34.5 in performing this function (He et al., 1996) . Recently, two host proteins that interact with the ICP34.5 protein have been identified. It has been proposed that the interaction of ICP34.5 with protein phosphatase 1 (PP1) α directs PP1 to dephosphorylate eIF-2α and thus prevent shut-off of host protein synthesis (He et al., 1997) . ICP34.5 is found in a complex with PP1 in infected cells and the sequence in ICP34.5 required for this interaction has been defined (He et al., 1998) . ICP34.5 and the conserved C-terminal domain of MyD116 have both been shown to bind proliferating cell nuclear antigen (PCNA) (Brown et al., 1997) , implying that the conserved C-terminal domain is required for this binding.
Deletion of the short form of this ASFV gene from the genome of a pathogenic isolate, E70, did not affect virus growth in swine macrophages or Vero cell cultures in vitro, but significantly reduced virulence of the virus in pigs. Reinsertion of the gene in this deletion mutant restored virulence (Zsak et al., 1996) . This shows that, like the HSV ICP34.5 gene, this ASFV gene can modulate virus virulence. As a first step towards defining how the l14L protein functions, we have studied its expression and localization in cells. Our results show that both the long and short forms of the l14L protein are localized predominantly in the nucleus, but that the long form is also targeted to the nucleolus. This suggests a possible nuclear function for the protein.
Methods
Cell cultures and viruses. Pig macrophages were prepared by lung lavage or as the adherent cell population from peripheral blood. These were maintained in Eagle's medium containing 10 % ox serum and were infected with different ASFV isolates at an m.o.i. of about 3. BS-C-1 cells were maintained in Dulbecco's modified Eagle's medium containing 10 % ox serum and were infected with the MVA T7 strain of vaccinia virus (VV) (Sutter et al., 1995) at an m.o.i. of 3-5. The ASFV isolates used were described by Sun et al. (1995) except for OurT88\1, OurT88\2, OurT88\3 (Boinas, 1994) , Ang72, Zim91, Kat67 and MVMT90\1 (from P. Wilkinson, IAH Pirbright, UK).
PCR and nucleotide sequence analysis. Fragments containing l14L genes and flanking sequences were amplified by PCR with virus DNA from the red blood cell fraction of ASFV-infected pig blood as template and primers designed from the BA71V DNA sequence positions 164037-164066, 5h CGTCAGAATCCCAAGGCAGGTCAGTTG-CGC, and 165071-165099, 5h GGTAAGGGATCCCTAATACGCT-CCTACC. PCR products were purified from agarose gels and cloned in the T-tailed vector pGEM-T (Promega). Sequences of inserts were determined by using T7 and SP6 primers or internal primers and T7 DNA polymerase by the dideoxy chain termination method. Reactions were run on an ALF express automatic sequencer (Pharmacia). The sequences were assembled and analysed using programs of the University of Wisconsin Genetics Computer Group.
Construction of epitope-tagged versions of the l14L gene.
Complementary oligonucleotides, 5h GGCGGTACCATGGCTTACCC-ATACGATGTTCCAGATTACGCTGAATTCCGG and 5h CCGGAA-TTCAGCGTAATCTGGACATCGTATGGGTAAGCCATGGTACC-GCC, encoding a 10 amino acid peptide (YPYDVPDYA) derived from the haemagglutinin protein (HA) of human influenza virus plus an N-terminal translation initiation codon, were annealed together. The annealed oligonucleotides were digested at KpnI and EcoRI sites included at the 5h and 3h ends and cloned into the respective sites in the pcDNA3 vector (Invitrogen) downstream of the CMV immediate early and T7 promoters. The short form of the l14L gene from the Lillie isolate was amplified by PCR with the primers 5h AAAGAATTCATGGGGG-GGCGGCGGCGC and 5h TTTTCTAGAGACTTCTTACTGCTGCT-CCAG and virus DNA purified from the red blood cell fraction of ASFVinfected pig blood as template (a gift of P. Wilkinson, IAH Pirbright, UK). The purified product was digested at EcoRI and XbaI sites that were included in the primers and cloned downstream of the HA tag in the pcDNA3 vector to create plasmid HAl14L(short). The long form of the l14L gene, from the Malawi LIL20\1 isolate, was amplified from clone LMW23 by using primers from the 5h and 3h ends of the coding region and including EcoRI and XbaI sites, in order to facilitate cloning downstream of the HA tag in the pcDNA3 vector to give plasmid HAl14L(long). A PCR fragment containing the l14L gene from the Malawi LIL20\1 isolate lacking the 14 N-terminal amino acids was amplified by using primers 5h AAAGAATTCCCTCTTAATACCA-TTCAACCAGG and 5h GGATCCCCGGGCTACTCATGCTCCAT-GGG. The fragment was digested by using sites incorporated into the primers (EcoRI and BamHI) and cloned downstream of the HA tag in the pcDNA3 vector to give plasmid HA∆Nl14L. In order to clone the 14 N-terminal amino acids of the long form of the l14L gene upstream of the β-galactosidase (β-gal) gene, the β-gal gene was excised from the pcDNA3 HislacZ plasmid (Invitrogen) with KpnI and EcoRI and cloned in pcDNA3. A fragment including the HA tag and 14 N-terminal amino acids of the l14L gene from Malawi LIL20\1 was amplified by PCR from plasmid HAl14L by using the T7 primer and primer 5h GGGG-TACCTTTGCACGTCGGCGGCTGC. This fragment was digested with KpnI and cloned upstream of the β-gal gene in the pcDNA3 vector to give plasmid HAl14LNgal. The l14L(long) gene and HA tag were excised from plasmid HAl14L(long) and cloned downstream of the ASFV p32 promoter in plasmid KSp32 (C. C. Abrams and L. K. Dixon, unpublished results) to give plasmid p32HAl14L(long). To clone the short form of the l14L gene, lacking its 14 N-terminal amino acids, downstream from the 14 N-terminal amino acids of the long form and the HA tag, the primer 5h AAAGGTACCCAGGTCCGCTTTGCTGCAGCCGTC and a primer from the 3h end of the short-form gene coding sequence were used to amplify the appropriate fragment. This was digested at KpnI and XbaI sites included in the primers and cloned downstream of the HA tag and the 14 N-terminal amino acids of l14L in the pcDNA3 vector. Sequencing of inserts was carried out to confirm that HA tags were in-frame and that the sequence was as expected. The plasmids were also transfected into MVAT7-infected cells and extracts were analysed by SDS-PAGE followed by Western blotting with anti-HA antibodies to confirm that proteins of the predicted sizes were expressed. Production of antisera against l14L. The coding region of the l14L gene from the Malawi LIL20\1 isolate genome was amplified by PCR with primers 5h ACAGTGGATCCATGTCGAGGAGAAAT-AAACGC and 5h GGATCCCCGGGCTACTCATGCTCCATGGG. The PCR product was digested at BamHI sites incorporated into the primers and cloned in-frame with the glutathione S-transferase (GST) gene in the pGEX-2T vector (Pharmacia). Expression of a GST fusion protein of the expected size (about 50 kDa) was induced with IPTG and the fusion protein was purified by glutathione-Sepharose affinity chromatography. Two New Zealand white rabbits were inoculated with 100 µg each of the purified fusion protein in Freund's complete adjuvant and boosted on days 21 and 42 with the same quantity of protein in Freund's incomplete adjuvant. Sera were collected on day 63.
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Western blotting. Cell extracts were harvested at various times post-infection in 50 mM Tris-HCl (pH 7n5), 120 mM NaCl, 2 % (v\v) NP-40, separated by SDS-PAGE on 12 % gels and transferred to nitrocellulose membranes (Hybond C ; Amersham). Membranes were blocked in PBS containing 5 % milk powder and 0n1 % Tween 20 and incubated with antiserum against the GST-l14L fusion protein (1 : 500) followed by HRP-conjugated anti-rabbit serum (1 : 2000). Bound antibodies were detected by ECL (Amersham).
Cell transfections. Plasmid DNA (5 µg) was mixed with lipofectin (1 mg\ml ; Life Technologies) and added to cells in the presence of Optimem medium (Life Technologies). Cells were incubated overnight for 16 h and processed for immunofluorescence as described below.
Immunofluorescence. Cells grown on coverslips were washed in PBS and fixed in 3 % paraformaldehyde for 20 min. After washing in PBS, cells were incubated with 50 mM NH % Cl and then with 0n2 % Triton X-100 for 5 min each. After blocking in PBS containing 0n2 % gelatin and 2 % goat serum, primary antibody was added for 1 h. After washing in blocking buffer, FITC-or TRITC-conjugated secondary antibody (1 : 16 to 1 : 80) was added for 1 h. Coverslips were rinsed in water, mounted in Mowiol and viewed under UV light. Controls carried out in parallel were infected and mock-transfected cells incubated with primary and secondary antibodies together and separately and cells transfected with plasmid expressing the protein of interest incubated with each antibody separately. Antibodies used were a rat monoclonal antibody against the HA epitope (Boehringer), rabbit anti-Nopp140 serum (Meier & Blobel, 1992) , a human antiserum that recognizes coiled bodies and nucleoli (Okano et al., 1992) and appropriate FITC-and TRITC-conjugated secondary antibodies from Dako.
Results

Comparison of the l14L gene from different ASFV isolates by PCR and nucleotide sequencing
The conservation of the long or short form of the l14L ORF in the genomes of 18 different virulent and non-virulent ASFV isolates from disease outbreaks in different regions was examined by PCR and nucleotide sequence analysis (Table 1) . Primers were from the Ba71V genome sequence and flanked the l14L-homologous ORF (DP71L), just upstream of the DP148 ORF and from within the DP96R ORF (Yanez et al., 1995) . Fragments obtained from 14 of the isolates were the same length (" 1100 bp) and were of the size predicted from the Ba71V genome sequence (1062 bp), whereas those from the remaining six isolates were longer and varied in length (" 1600 to 1900 bp) ( Table 1) . Primers used to amplify the l14L Fig. 4 . Localization of the long and short forms of the l14L protein. BS-C-1 cells were infected with the MVA T7 strain of VV and transfected with plasmids HAl14L(long) (a, b), HAl14L(short) (c, d) or HA∆NI14L (e, f) (see Methods and Fig. 3 ). After incubation for 16 h, cells were stained with rat anti-HA monoclonal antibodies (a, c, e) or rabbit anti-Nopp140 antibodies (b) or a human serum that recognizes nucleoli and coiled bodies (d, f). FITC-conjugated goat anti-rat antibodies were used with rat anti-HA antibodies and TRITC-conjugated anti-rabbit antibodies were used with rabbit anti-Nopp140 antibodies. Magnification, i600. ORF from the Bon83 isolate were designed by using the Malawi LIL20\1 sequence and flanked the ORF closely.
PCR fragments obtained from eight of these isolates (Bon83,Tanz87, Bur84\2, Ug-A, Moz60, Lillie, RSA85\1, Lis60 and Lis57) were cloned into pGEM-T and the nucleotide sequences of the encoded l14L-homologous ORFs were determined. This showed that the l14L ORFs from the Lillie, RSA85\1, Lis60 and Lis57 isolates were the same length as the short form of the gene identified in the Ba71V isolate genome (213 bp), whereas those from the Bon83, Bur84\2, Tanz87, Moz60 and Ug-A isolates were very similar to the l14L ORF encoded by the Malawi LIL20\1 isolate (552 or 555 bp) (Fig.  1) . The predicted proteins encoded by the short form of the gene were identical in sequence, whereas those encoded by the long forms of the gene shared between 89 and 100 % identity. The Bon83 and Malawi LIL20\1 sequences were identical and differed from the Moz60 sequence at one residue. The Bur84\2 and Ug-A sequences were very similar but differed from the Malawi LIL20\1 isolate at 12 or 13 residues. The Tanz87 isolate was most different from other isolates and varied at 21 residues compared with the Malawi LIL20\1 isolate. Sequences within the C-terminal domain that are conserved in the ICP34.5, MyD116 and GADD34 proteins were conserved in the different ASFV sequences. The N-terminal basic domain was also present in all the l14L proteins, although three isolates had 11 Arg\Lys residues in this domain rather than 10 as encoded by the Malawi LIL20\1 isolate, and the short form of the protein had seven Arg\Lys residues. The length differences in PCR fragments from different isolates were explained by differences in the length of both the l14L ORFs and the intergenic region upstream (data not shown).
The l14L protein is expressed late during ASFV infection
Antisera were raised against the l14L protein to study its expression in virus-infected cells. For this purpose, the complete l14L ORF from the Malawi LIL20\1 isolate was expressed in E. coli as a GST fusion protein. This fusion protein, which migrated with the expected molecular mass on SDS-PAGE (" 48 kDa ; data not shown), was purified by glutathione-Sepharose chromatography and used to immunize rabbits. To confirm that the antiserum recognized the l14L protein specifically, the l14L ORF was cloned downstream of a T7 promoter in the pcDNA3 vector (Invitrogen), to give plasmid T7l14L, and expressed transiently following transfection of this plasmid into cells that had been infected with the MVA strain of VV expressing T7 RNA polymerase (Sutter et al., 1995) . A band of 21 kDa (the predicted molecular mass of the l14L-encoded protein) was detected by Western blotting of extracts from cells that had been transfected with the l14L expression plasmid (Fig. 2 b) but not in cells transfected with a plasmid containing the l14L ORF in the anti-sense orientation. This band was not detected by pre-immune serum (Fig. 2 b) . The antisera also reacted on Western blots with the E. coliexpressed GST-l14L fusion protein (data not shown).
These results confirmed that the antisera reacted specifically with the l14L protein. Pig macrophages obtained either from peripheral blood or by lung lavage were infected with the Malawi LIL20\1 ASFV isolate. At various times post-infection, cells were harvested and extracts separated by SDS-PAGE were transferred to nitrocellulose membranes and probed with the l14L antiserum. A protein of molecular mass of 21 kDa was detected in cells harvested at late times post-infection (8, 16 or 24 h) but not in uninfected cell extracts or extracts harvested at early times post-infection (2, 4 or 6 h) (Fig. 2 a) . This 21 kDa protein was not detected in cells incubated for 24 h in the presence of cytosine arabinoside (Fig. 2 a) , an inhibitor of late gene expression, confirming that the l14L protein is expressed late during ASFV infection. The antiserum also reacted with a 15 kDa protein present in extracts from peripheral blood macrophages but not in extracts from alveolar macrophages. A protein migrating with the same mobility was detected, albeit in lesser amounts, in uninfected peripheral blood macrophages. This 15 kDa protein is possibly a host cell protein, present in peripheral blood but not alveolar macrophages, that crossreacts with the anti-GST-l14L antiserum.
Localization of the long and short forms of the l14L protein in cells
The antiserum raised against the GST-l14L fusion protein did not react when assayed by immunofluorescence (data not shown) and could therefore not be used easily to localize the l14L protein within cells. Instead, a double-stranded oligonucleotide encoding the HA-epitope tag was inserted upstream of both the long form and the short form of the l14L gene (from the Malawi LIL20\1 and Lillie isolates, respectively) in the pcDNA3 vector (Fig. 3) . The encoded proteins were expressed following transfection into cells that had been infected with the MVA strain of VV expressing T7 RNA polymerase (Sutter et al., 1995) and were detected by immunofluorescence by using a rat anti-HA monoclonal antibody and appropriate FITC-conjugated secondary antibody. The long form of the l14L protein was detected mainly in the nucleus of transfected cells. Although staining was detected throughout the nucleus, intense staining was observed in large bodies within the nucleus that resembled nucleoli (Fig. 4 a) . In order to confirm that these structures were nucleoli, co-staining was carried out with an antiserum that recognized a nucleolar protein (Nopp-140 ; Meier & Blobel, 1992 ) and a TRITC-conjugated secondary antibody (Fig. 4 b) . Some small, intensely stained specks were also detected within the nucleus with the anti-HA antibodies (Fig. 4 a) . These did not co-localize with areas stained by antibodies that recognize coiled bodies or ND10 bodies (data not shown) and the structures they represent remain unknown. A small amount of cytoplasmic staining could also be detected with the anti-HA antibodies.
When localization of the HA-tagged short form of the l14L protein was studied by immunofluorescence, a different distribution of the protein was observed (Fig. 4 c) . Although staining was detected throughout the nucleus, no intensely stained areas were observed. In contrast to the results obtained with the long form of the protein, staining of the short form of the protein was reduced within the nucleoli compared with the rest of the nucleus (Fig. 4 d ) .
Deletion of the N-terminal basic domain from the long form of the l14L protein abolishes nucleolar localization of the protein
Examination of the predicted l14L protein sequence showed that the Arg\Lys-rich region at the N terminus of the protein resembles nucleolar localization signals (NoLS) described in several other viral proteins such as human immunodeficiency virus type 1 (HIV-1) Rev, human T-lymphotropic virus type I (HTLV-I) Rex and the MEQ protein of Marek's disease virus (MDV) (Kubota et al., 1996 ; Siomi et al., 1988 ; Liu et al., 1997) . Table 2 shows a comparison between the NoLS of these proteins and the Arg\Lys-rich domains at the N terminus of the l14L long-and short-form proteins and the HSV ICP34.5 protein. In order to determine whether the N-terminal domain of the long form of the l14L protein contained residues required for nucleolar localization, sequences encoding the Nterminal 14 amino acids were deleted from the gene and the HA-epitope tag was fused upstream of this mutated gene in the pcDNA3 vector. Localization of the expressed protein in transfected cells was examined as before. Staining was detected in both the nucleus and cytoplasm of transfected cells but no intense staining of the nucleoli was observed (Fig. 4 e) . These results demonstrate that deletion of the N-terminal 14 amino acids of the long form of the l14L protein prevents its nucleolar localization, suggesting that these amino acids may contain the sequences required for nucleolar targeting.
The N-terminal 14 amino acids of the long form of the l14L protein are sufficient to confer nucleolar localization
In order to test whether the N-terminal 14 amino acids of the long form of the l14L protein can direct nucleolar localization of a protein that is normally present in the cytoplasm, sequences encoding these residues were fused downstream of the HA tag at the N terminus of the β-gal gene and of the l14L short-form gene lacking its own 14 N-terminal amino acids. These plasmids were transfected into cells infected with MVA T7. Staining with anti-HA antibodies showed that the modified β-gal protein was localized predominantly in the nuclei of transfected cells. Within the nuclei, intense staining was observed in the nucleoli (Fig. 5 a, b) . In contrast, in cells transfected with plasmids expressing HA-tagged β-gal that lacked these N-terminal amino acids from the l14L protein, staining with antibodies detected β-gal throughout the cell (Fig. 5 c, d) . The modified short-form l14L protein, with the Nterminal 14 amino acids replaced with those from the longform l14L protein, localized predominantly to the nucleolus, showing a typical nucleolar staining pattern ( Fig. 5 e, f) . These results confirm that the N-terminal 14 amino acids from the long form of the l14L protein contain the sequences necessary to localize proteins to the nucleolus.
The l14L protein is localized to the nucleus and nucleolus in ASFV-infected cells
In order to confirm that the l14L protein is also localized in the nucleus and nucleolus in ASFV-infected cells, the HAtagged l14L(long) gene was cloned downstream of the ASFV p32 promoter. Experiments comparing expression of a luciferase reporter gene cloned downstream of this promoter and the l14L promoter had shown that, when transfected into ASFV-infected cells, the timing and level of expression from these promoters were very similar (C. C. Abrams and L. K. Dixon, unpublished results) . We therefore suggest that the localization of the protein expressed from the transfected plasmid is similar to that of the l14L protein expressed from the ASFV genome during infection. However, it is possible that differences in the level of expression may result in an altered distribution of the protein during ASFV infection. For example, higher expression levels may result in a greater proportion of the protein being found throughout the nucleoplasm or in the cytoplasm. This plasmid was transfected into Vero cells that had been infected with the Ba71V ASFV isolate. After 16 h, the HA-tagged l14L protein was localized by immunofluorescence by using anti-HA antibodies and FITC-conjugated secondary antibodies. This showed that the l14L(long) form, when expressed in the context of an ASFV infection, was also localized to the nucleus and nucleolus of infected cells (Fig.  5 g, h) . In some cells, staining was mainly in the nucleolus with a small amount of staining throughout the nucleoplasm. In some other cells, in which higher expression levels were (HANl14L β-gal) (a) , the short form l14L lacking its Nterminal 14 amino acids (e) or the HA tag fused directly to the β-gal gene (HAβ-gal) (c) were transfected into MVA T7-infected cells. (g) Vero cells transfected with plasmid p32HAl14L (long), which contains the HA-tagged l14L gene downstream of the ASFV p32 promoter, and infected with the BA71V ASFV isolate. Co-staining of nucleolar proteins with a human serum that recognizes nucleoli and coiled bodies is also shown (b, d, f, h) . Cells were fixed and permeabilized 16 h post-infection and HA-tagged forms of β-gal were detected with rat anti-HA antibodies and FITC-conjugated goat anti-rat secondary antibodies. Magnification, i400. FDC observed, greater staining was observed throughout the nucleoplasm, although the nucleoli were still most intensely stained (data not shown).
Discussion
Our analysis of the genomes of a wide range of ASFV isolates suggests, in agreement with a previous report (Zsak et al., 1996) , that genes related to l14L are well conserved in the virus genome, since all isolates analysed encode either a long or short form. Previously, only the Malawi LIL20\1 isolate has been found to encode a long form of the gene. We have characterized an additional five isolates that encode the longer form of the gene, demonstrating that this gene form is widely distributed in isolates from eastern Africa. The length of the gene encoded does not correlate with virus virulence, since virulent isolates can encode either a long or a short form of the gene.
By using HA epitope-tagged forms of l14L genes, we localized the l14L protein by immunofluorescence. This showed that most of the long form of the protein was present in the nucleus, largely in nucleoli, although some was also detected as a diffuse staining throughout the nucleoplasm and in small, intensely stained particles. In contrast, although most of the short-form protein was also in the nucleus, it was not in nucleoli. Inspection of the sequence of the l14L protein showed that the basic, Arg\Lys-rich region at the N terminus resembled NoLS that have been described in other viral and cellular proteins, including HIV-1 Rev (Kubota et al., 1996) , HTLV-I Rex (Siomi et al., 1988) , several herpesvirus proteins such as MDV MEQ (Liu et al., 1997) and parathyroid hormone-related peptide (Henderson et al., 1995) . Effective localization of most proteins to the nucleolus appears to be dependent on the presence of a nuclear localization signal (NLS) together with additional functional domains (Schmidt-Zachmann & Nigg, 1993 ; Yan & Melese, 1993) . For the viral and cellular proteins described above, the NoLS consists of an NLS associated with longer arrays of Arg\Lys amino acids. These basic residues are proposed to be targeted to the nucleolus by binding either to an acidic region in the nucleolar protein B23 or to rRNA (Adachi et al., 1993) .
The basic domain at the N terminus of the long form of the l14L protein contains either 10 or 11 Arg\Lys residues, whereas the short form of the protein has only seven Arg\Lys residues and one His residue. It is possible that the reduced number of Arg\Lys residues at the N terminus and\or some other structural features of the short protein mean it does not contain an NoLS. Evidence that the number of Arg\Lys residues is important for a sequence to function as an NoLS comes from mutagenesis of NoLS. For example, the MEQ protein contains two separate Arg\Lys-rich regions, BR1, which contains six residues, and BR2, which consists of two Arg\Lys-rich regions (BR2N and BR2C) of five and six residues separated by five residues. Although the BR1, BR2N and BR2C sequences were each sufficient to confer nuclear localization to a cytoplasmic protein (v-Raf kinase), both the BR2N and BR2C sequences were required for nucleolar targeting (Liu et al., 1997) . However, the NoLS of the HTLV-I Rex protein is also relatively short, containing only nine Arg\Lys residues. It has also been suggested that a Gln residue is required as part of the NoLS (Dang & Lee, 1989) . Our results do not support this hypothesis, since the 14 amino acids from the N terminus of l14L(long), which were sufficient to confer nucleolar localization, do not contain a Gln residue. Although deletion of the N-terminal 14 amino acids from the long form of the l14L protein abolished its nucleolar localization, a large proportion of this mutant protein was present in the nucleus. This suggests either that the protein contains another NLS and is actively transported to the nucleus or that the protein diffuses across nuclear pores and is retained in the nucleus by binding to a nuclear factor.
The significance of targeting of the l14L protein to the nucleolus and nucleus is not clear, since little is known about how the protein functions. The sequence similarity between the C-terminal domain of l14L and domains in the HSV ICP34.5, MyD116 and GADD34 proteins suggests a possible common function. The ICP34.5 protein is thought to have more than one function. It has been shown to prevent host protein synthesis shut-off caused by phosphorylation of the translation initiation factor elF2-α (Chou et al., 1995) , and it has been proposed that it achieves this by binding to PP1 and redirecting PP1 to dephosphorylate elF2-α (He et al., 1997) . The sequence required for binding of ICP34.5 to PP1 has been defined and is also present in the l14L sequence (He et al., 1998) . Interestingly, HSV encodes a second protein, U S 11, which, if expressed early in infection, can compensate for deletion of the ICP34.5 gene and prevent shut-off of protein synthesis mediated by PKR kinase (Cassady et al., 1998) . The U S 11 protein acts by a different mechanism to ICP34.5 and binds to the PKR kinase, preventing phosphorylation of eIF-2α (Cassady et al., 1998) .
Additional functions for ICP34.5 are suggested by the observation that the protein binds to PCNA (Brown et al., 1997) . Binding to PCNA is probably mediated by the conserved C-terminal domain, since this domain of MyD116 alone also binds to PCNA (Brown et al., 1997) . PCNA acts as a processivity factor for DNA polymerase γ and in recruitment of replication factors to DNA replication sites. The p21 cyclindependent-kinase inhibitor also binds to PCNA, and inhibits DNA replication catalysed by DNA polymerase δ holoenzyme, but does not block nucleotide-excision repair of DNA (Flores-Rozas et al., 1994 ; Li et al., 1994 ; Waga et al., 1994) . Binding of ICP34.5 to PCNA may interfere with its interaction with p21 and prevent inhibition of DNA replication (Brown et al., 1997) . Continued cellular DNA synthesis may be necessary to provide factors required for viral DNA replication, and might prevent cells going into a growth-arrest state induced by virus infection (Brown et al., 1997) . In common with the FDD long form of the l14L protein, PCNA is present in both the nucleus and nucleolus (Waseem & Lane, 1990 ), suggesting that l14L may interact with PCNA or a related protein. The HSV U S 11 protein has also been found in the nucleolus, as well as in association with ribosomes in the cytoplasm (MacLean et al., 1987 ; Roller & Roizman, 1992) . Interestingly, sequence comparison of the N-terminal residues of ICP34.5 with those of l14L and other NoLS (Table 2) suggests that ICP34.5 may also be targeted to the nucleolus. The accumulation of l14L in the nucleolus may not be inconsistent with a role in preventing shut-off of protein synthesis, as it may bind to pre-ribosomal particles in the nucleolus. We cannot rule out that the l14L protein is present in the cytoplasm, as a small amount of protein present throughout the cytoplasm may not have been detected by using immunofluorescence or may have been masked by incorporation into cytoplasmic structures (e.g. ribosomes).
In contrast to the proposed function for ICP34.5 in preventing growth arrest, MyD116 and GADD34 are induced under conditions that lead to growth arrest and apoptosis, suggesting a role for these proteins in induction of these processes. The MyD116 gene was originally isolated as one of several genes induced following induction of terminal differentiation associated with growth arrest, which culminates in apoptosis of the M1 myeloblastic leukaemia cell line (Lord et al., 1990 ; Selvakumaran et al., 1993 ; Zhan et al., 1994) . The GADD34 gene is one of a series induced as a result of DNA damage (Fornace et al., 1989) and is very similar to MyD116 (71 % identical, 87 % similar) (Zhan et al., 1994) .
Growth-arrest responses in cells, including the activation of various checkpoints, differentiation, apoptosis and cell necrosis, are regulated by complex interactions involving various proteins. It is possible that the protein family that includes MyD116 and GADD34 may act as either positive or negative regulators of these processes, in a similar way to the Bc1-2\Bax family of apoptosis regulators. The l14L protein may either mimic or block the function of proteins such as MyD116 and GADD34, leading to modulation of the differentiation, growth or apoptotic states. The activity of the protein may therefore depend on the cells in which it is expressed and its level of expression. This might help to explain why deletion of the gene from the genome of the E70 isolate did not affect ASFV replication in macrophages or tissue culture cells but caused a significant reduction in virus virulence for pigs, possibly due to an alteration in cell tropism of the virus (Zsak et al., 1996) .
The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the γ(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. Journal of Virology 70, 84-90. B., Gross, M. & Roizman, B. (1997) . The γ(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 FDE
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